Chinese Insulin Wins FDA Nod: Sunshine Lake Pharma Breaks Into US Market
Sunshine Lake Pharma, the Chinese mainland’s first to gain FDA approval for a long‑acting insulin, is set to supply 18 million vials to the United States over 18 months.
US Market
Japan’s Economic Challenges Test Takaichi’s Reform Agenda in 2026
Japan faces structural economic hurdles in 2026 as PM Takaichi’s growth agenda confronts inflation, aging demographics, and global market shifts, experts caution.